Updating the omeract filter: Discrimination and feasibility

Journal of Rheumatology

Volumn 41, Issue 5, 2014, Pages 1005-1010

  Wells, George ^a   Beaton, Dorcas E ^d   Tugwell, Peter ^a   Boers, Maarten ^b   Kirwan, John R ^c   Bingham, Clifton O ^e   Boonen, Annelies ^f   Brooks, Peter ^g   Conaghan, Philip G ^h   D'Agostino, Maria Antonietta ⁱ   Dougados, Maxime ^j   Furst, Daniel E ^k   Gossec, Laure ^l   Guillemin, Francis ^m   Helliwell, Philip ^h   Hewlett, Sarah ⁿ   Kvien, Tore K ^o   Landewé, Robert B ^p   March, Lyn ^q   Mease, Philip J ^r   OØstergaard, Mikkel ^s   Simon, Lee ^t   Singh, Jasvinder A ^t   Strand, Vibeke ^u   Van Der Heijde, Désirée M ^v   more..

^a UNIVERSITY OF OTTAWA   (Canada)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF TORONTO   (Canada)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h UNIVERSITY OF LEEDS   (United Kingdom)

ⁱ LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^j UNIVERSITÉ PARIS DESCARTES   (France)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l Pitié salpêtriè'Re Hospital   (France)

^m UNIVERSITÉ DE LORRAINE   (France)

ⁿ UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^o DIAKONHJEMMET HOSPITAL   (Norway)

^p UNIVERSITY OF AMSTERDAM   (Netherlands)

^q UNIVERSITY OF SYDNEY   (Australia)

^r UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^s Mental Health Services CPH   (Denmark)

^t UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^u STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^v LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

Discrimination; Feasibility; Outcome And Process Assessment; Outcome Measures In Rheumatology

Indexed keywords

ARTICLE; CLASSIFICATION ALGORITHM; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; CONCEPTUAL FRAMEWORK; CONSENSUS DEVELOPMENT; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DIGITAL FILTERING; FEASIBILITY STUDY; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INTERMETHOD COMPARISON; OUTCOME MEASURES RHEUMATOLOGY; PRIORITY JOURNAL; PROCESS DESIGN; PROCESS DEVELOPMENT; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SENSITIVITY ANALYSIS; SYSTEM ANALYSIS; CLASSIFICATION; EVIDENCE BASED MEDICINE; PERCEPTIVE DISCRIMINATION; RHEUMATIC DISEASES; RHEUMATOLOGY; STANDARDS; TREATMENT OUTCOME; TRENDS;

DISCRIMINATION (PSYCHOLOGY); EVIDENCE-BASED MEDICINE; FEASIBILITY STUDIES; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); RHEUMATIC DISEASES; RHEUMATOLOGY;

EID: 84899757716     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.131311     Document Type: Article

References (17)

1. Beaton DE, Bombardier C, Katz JN, Wright JG, Wells G, Boers M, et al. Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome measures in rheumatology. Minimal clinically important difference. J Rheumatol 2001;28:400-5.
2. Jaeschke R, Singer J, Guyatt GH. Ascertaining the minimal clinically important difference. Cont Clin Trials 1989;10:407-15.
3. Kirwan Jr. Minimum clinically important difference: The crock of gold at the end of the rainbow. J Rheumatol 2001;28:439-44. (Pubitemid 32165166)
4. Rennard SI. Minimal clinically important difference, clinicalperspective: an opinion. COPD 2005;2:51-5. (Pubitemid 40776223)
5. Beaton DE, Boers M, Wells GA: Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Curr Opin Rheumatol 2002; 14:109-14. (Pubitemid 34185291)
6. Gatchel RJ, Mayer TG. Testing minimal clinically important difference: consensus or conundrum? Spine J 2010;10:321-7.
7. Dougados M, Moore A, Yu S, Gitton X. Evaluation of the patient acceptable symptom state in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis. Arthritis Res Ther 2007;9:R11.
8. Wells G, Beaton D, Shea B, Boers M, Simon L, Strand V, et al. Minimal clinically important differences: review of methods. J Rheumatol 2001;28:406-12. (Pubitemid 32165161)
9. Feinstein AR. Clinimetrics. New Haven: Yale University Press; 1987.
10. Rowe BH, Oxman AD. An assessment of the sensibility of a quality of life instrument. Am J Emerg Med 1993;11:374-80. (Pubitemid 23227915)
11. Auger C, Demers L, Swaine B. Making sense of pragmatic criteria for the selection of geriatric rehabilitation measurement tools. Arch Gerontol Geriatr 2006;43:65-83. (Pubitemid 43866961)
12. Boers M, Brooks P, Strand V, Tugwell P. The OMERACT Filter for outcome measures in rheumatology. J Rheumatol 1998;25:198-9.
13. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol 1997;50:683-91. (Pubitemid 27341818)
14. Wells G, Sultan S, Chen L, Coyle D. Indirect evidence: indirect treatment. Comparisons in meta-analysis. Ottawa: Canadian Agency for Drugs and Technology in Health (CADTH) Health Technology Report; 2009.
15. Strand V, Crawford B. Improvement in health-related quality of life in patients with SLE following sustained reductions in anti-dsDNA antibodies. Expert Rev Pharmacoecon Outcomes Res 2005; 5:317-26. (Pubitemid 40894969)
16. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN Checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: An international Delphi study. Qual Life Res 2010;19:539-49.
17. Boers M, Kirwan JR, Wells G, Beaton D, Gossec L, d'Agostino MA, et al. Developing core outcome measurement sets for clinical trials: OMERACT Filter 2.0. J Clin Epidemiol 2014 Feb 27 (E-pub ahead of print).